| [1] |
Walker PP, ReynoldsMT, Ashbee HR, et al. Vaginal yeasts in the era of"over the counter"antifungals[J]. Sex Transm Infect, 2000, 76(6):437-438.
|
| [2] |
Fidel PL, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis[J]. Clin Microbiol Rev, 1996, 9(3):335-348.
|
| [3] |
Liu ZH, Liao QP. An epidemic investigation on vulvovaginal candidiasis patients in high incident regions and low incident regions[J]. Chin Genl Pract, 2006, 9(8):630-631.
|
| [4] |
Fidel PL Jr. Immunity in vaginal candidiasis[J]. Curr Opin Infect Dis, 2005, 18(2):107-111.
|
| [5] |
Faro S. Vaginitis: Differential diagnosis and management[M]. Boca Raton:Parthenon Pub Group, 2004, 45-65.
|
| [6] |
Sobel JD. Vulvovaginal candidosis[J]. Lancet, 2007, 369(9577):1961-1971.
|
| [7] |
Takanhashi K, Ezekowits RA. The role of the mannose binding lectin in innate immunity[J]. Clin Infect Dis, 2005, 41(7):440-444.
|
| [8] |
Ikeda K, Sannoh T, Kawasaki N, et al. Serum lectin with known structure activates complement through the classical pathway[J]. J Biol Chem, 1987, 262:7451.
|
| [9] |
Tabona P, Mellor A, Summerfield JA. Mannose binding protein is involved in first-line host defence: Evidence from transgenic mice[J]. Immunolgy, 1995, 85(1):153.
|
| [10] |
Neth O, Jack DL, Dodds AW, et al. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition[J]. Infect Immune, 2000, 68:688-693.
|
| [11] |
Giraldo PC, Babula O, Goncalves AK, et al. Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis[J]. Obstet Gynecol, 2007, 109(5):1123-1128.
|
| [12] |
Donders GG, Babula O, Bellen G, et al. Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis[J]. BJOG, 2008, 115(10):1225-1231.
|
| [13] |
Henic E, Thiel S, M？rdh PA. Mannan-binding lectin in women with a history of recurrent vulvovaginal candidiasis[J]. Eur J Obstet Gynecol Reprod Biol, 2010, 148(2):163-165.
|
| [14] |
Li CY, Li Y. Etiology and control measures of recurrent vulvovaginal candidiasis[J]. Chin J Dermatol, 2006, 39(8):4892.
|
| [15] |
Hu C, Wu XL. Etiopathogenis study of vulvovaginal candidiasis[J]. Med Recapitul, 2008, 14(7):1043-1044.
|
| [16] |
Wojitani MD, de Aguiar LM, Baracat EC, et al. Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis[J]. Arch Gynecol Obstet, 2012, 285(1):149-153.
|
| [17] |
Milanese M, Segat L, De Seta F, et al. MBL2 genetic screening in patients with recurrent vaginal infections[J].Am J Reprod Immunol, 2008, 59(2):146-151.
|
| [18] |
Hua CZ, Sun LY, Luo QE, et al. SNP in 5'untranslated region of MBL gene and mannose binding lectin plasma concentration variation in children with infantile vaginitis in Hangshou, China[J]. Curr Immunol, 2011, 31(2):147-150.
|
| [19] |
Hua CZ, Sun LY, Luo QE, et al. SNPs of mannose binding lectin gene and its plasma concentration variation in children with infantile vaginitis in Hangzhou[J]. China Prev Med, 2011, 12(4):317-320.
|
| [20] |
Liu F, Liao Q, Liu Z. Mannose-binding lectin and vulvovaginal candidiasis[J]. Int J Gynaecol Obstet, 2006, 92(1):43-47.
|
| [21] |
Niu ZQ, Zheng HY, Shi YF. Potential role for mannose binding receptor in anti-Candida activity of mice vaginal epithelial cells[J]. Prog Obstet Gynecol, 2008, 17(5):358-368.
|